Home Institutions Mount Sinai clinical trials Institution Directory
Clinical trials at Mount Sinai Sites in New York, NY
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 30, 2026, 9:55 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1101
Current sort
Recently updated
Campus scope
Mount Sinai, New York, NY
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 613–624 of 1,101 matching trials with a site at Mount Sinai, New York, NY.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm
Interventions Biopsy Procedure, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Nilotinib Hydrochloride Monohydrate, Paclitaxel Procedure · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 40 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2027
U.S. locations 124
States / cities Birmingham, Alabama • Kingman, Arizona • Palo Alto, California + 101 more
Conditions Follicular Lymphoma (FL)
Interventions Epcoritamab, Prednisone, Rituximab, Lenalidomide, Doxorubicin, Vincristine, Cyclophosphamide, Obinutuzumab, Bendamustine Drug
Lead sponsor Genmab Industry
Eligibility 18 Years and older
Enrollment 1,095 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2037
U.S. locations 58
States / cities Fresno, California • San Diego, California • Santa Barbara, California + 48 more
Conditions Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies, Heart Diseases, Polyneuropathies
Interventions Acoramidis, Placebo oral tablet Drug
Lead sponsor Eidos Therapeutics, a BridgeBio company Industry
Eligibility 18 Years to 75 Years
Enrollment 587 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2032
U.S. locations 40
States / cities La Jolla, California • Los Angeles, California • San Francisco, California + 31 more
Conditions Long COVID, Chronic Fatigue Syndrome
Interventions Transcutaneous vagus nerve stimulator Device
Lead sponsor Icahn School of Medicine at Mount Sinai Other
Eligibility 21 Years to 70 Years
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 1
States / cities New York, New York
Conditions Crohn Disease
Interventions Interleukin-2 (aldesleukin). Drug
Lead sponsor Boston Children's Hospital Other
Eligibility 12 Years to 80 Years
Enrollment 30 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 3
States / cities Boston, Massachusetts • New York, New York
Conditions Type 2 Diabetes Mellitus
Interventions Device: Omnipod M System with study CGM, Standard Therapy plus study CGM Device
Lead sponsor Insulet Corporation Industry
Eligibility 18 Years to 75 Years
Enrollment 350 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 27
States / cities Los Angeles, California • Newport Beach, California • Santa Barbara, California + 23 more
Conditions Multiple Sclerosis, Myasthenia Gravis
Interventions CC-97540, Fludarabine, Cyclophosphamide Drug
Lead sponsor Juno Therapeutics, Inc., a Bristol-Myers Squibb Company Industry
Eligibility 18 Years to 60 Years
Enrollment 120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 16
States / cities Birmingham, Alabama • Irvine, California • Aurora, Colorado + 12 more
Conditions Lupus Erythematosus, Systemic, Lupus Nephritis
Interventions CC-97540, Fludarabine, Cyclophosphamide Drug
Lead sponsor Juno Therapeutics, Inc., a Bristol-Myers Squibb Company Industry
Eligibility 16 Years and older
Enrollment 89 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2032
U.S. locations 41
States / cities Phoenix, Arizona • Los Angeles, California • Newport Beach, California + 28 more
Conditions Bile Acid Synthesis Disorders
Interventions Cholbam Drug
Lead sponsor Mirum Pharmaceuticals, Inc. Industry
Eligibility Not listed
Enrollment 55 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2017 – 2039
U.S. locations 24
States / cities Birmingham, Alabama • Palo Alto, California • San Francisco, California + 18 more
Conditions Carotid Artery Calcification, Carotid Artery Diseases
Interventions Carotid Intravascular Lithotripsy Device
Lead sponsor Shockwave Medical, Inc. Industry
Eligibility 18 Years and older
Enrollment 185 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2032
U.S. locations 25
States / cities Scottsdale, Arizona • Aurora, Colorado • Jacksonville, Florida + 19 more
Conditions Hematological Malignancies
Interventions Teclistamab Drug
Lead sponsor Janssen Research & Development, LLC Industry
Eligibility 18 Years and older
Enrollment 194 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 10
States / cities Birmingham, Alabama • Duarte, California • San Francisco, California + 6 more
Conditions Cardiac Disease, Postoperative Pain
Interventions Rectus sheath block Procedure
Lead sponsor Icahn School of Medicine at Mount Sinai Other
Eligibility 18 Years to 85 Years
Enrollment 75 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2026
U.S. locations 1
States / cities New York, New York About this Mount Sinai institution page
What this page lists ClinicalTrials.gov records that list Mount Sinai in New York, NY as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .